,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"Cardiac Toxicities, Acute Renal Failure, Tumor Lysis Syndrome, Pulmonary Toxicity, Pulmonary Hypertension, Dyspnea, Hypertension, Venous Thrombosis, Infusion Reactions, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic Thrombocytopenic Purpura, Hemolytic Uremic Syndrome, Posterior Reversible Encephalopathy Syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, death, pneumonia, respiratory tract infection, pulmonary embolism, constipation, asthenia, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, muscle spasms, insomnia, rash, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, leukopenia, vomiting, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, headache, dizziness, peripheral neuropathies NEC, insomnia, dyspnea, cough, epistaxis, renal failure, hypertension, hepatic failure, bronchitis, nasopharyngitis, respiratory tract infection, hyperglycemia, hyperkalemia, hyperuricemia, hypoalbuminemia, hypocalcemia, hypomagnesemia, hypophosphatemia, musculoskeletal chest pain, erythema, rash, embolic and thrombotic events, venous, febrile neutropenia, cardiac arrest, cardiac failure congestive, pain, sepsis, urinary tract infection, hyperglycemia, hyperkalemia, hyperuricemia, hypoalbuminemia, hypocalcemia, hyponatremia, hypophosphatemia, renal failure, renal failure acute, renal impairment, pulmonary edema, hypotension."
1,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction, fatal outcome, myocardial ischemia, death, Acute Renal Failure, Tumor Lysis Syndrome, TLS, Acute Respiratory Distress Syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, Pulmonary Hypertension, Dyspnea, Hypertension, hypertensive crisis, Venous Thrombosis, deep venous thrombosis, pulmonary embolism, Infusion Reactions, fever, chills, arthralgia, myalgia, facial flushing, facial edema, vomiting, weakness, shortness of breath, hypotension, syncope, chest tightness, angina, Thrombocytopenia, Hepatic Toxicity, Hepatic Failure, Thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, TTP/HUS, Posterior reversible encephalopathy syndrome, PRES, Reversible Posterior Leukoencephalopathy Syndrome, RPLS, seizure, headache, lethargy, confusion, blindness, altered consciousness, visual disturbances, neurological disturbances, Embryo-fetal Toxicity, fetal harm"
2,MULTAQ,adverse reactions,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes (generalized, macular, maculo-papular, erythematous), pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis"
3,MULTAQ,boxed warnings,"death, stroke, heart failure"
4,MULTAQ,warnings and precautions,"AF, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, renal impairment, teratogen, cardiovascular death, heart failure, increased risk of stroke, new onset or worsening heart failure, hepatocellular liver injury, acute liver failure, interstitial lung disease, pneumonitis, pulmonary fibrosis, dyspnea, non-productive cough, QT interval prolongation, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, fetal harm, death"
5,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, Serious Adverse Reactions, Adverse Reactions Leading to Discontinuation, hypersensitivity, Gastrointestinal Disorders, Constipation, Vomiting, Laboratory Investigations, Increased transaminases, Metabolism and Nutrition disorders, Hypokalemia, Skin and Subcutaneous Tissue Disorders, Vascular Disorders, Phlebitis, Anemia, Eosinophilia, Neutropenia, Thrombocytopenia, Cardiac disorders, Bradycardia, Palpitations, Abdominal pain, Pyrexia, Hepatitis, Anaphylaxis, Clostridium difficile colitis, Hyperglycemia, Hyperkalemia, Dizziness, Convulsion, Renal failure, Urticaria, Agranulocytosis"
7,TEFLARO,warnings and precautions,"serious hypersensitivity reactions, anaphylactic reactions, serious skin reactions, Clostridium difficile-associated diarrhea (CDAD), fatal colitis, Direct Coombs' test seroconversion, drug-induced hemolytic anemia, development of drug-resistant bacteria, death"
8,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"hypersensitivity reactions, anaphylactic, skin erythema, pruritis, thyroid neoplasia"
10,TIVICAY,adverse reactions,"hypersensitivity reactions, effects on serum liver biochemistries, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, ALT abnormalities, AST abnormalities, creatine kinase abnormalities, hyperglycemia, lipase abnormalities, total neutrophils abnormalities, cholesterol increase, HDL cholesterol increase, LDL cholesterol increase, triglycerides increase, elevated total bilirubin, death"
11,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, severe rash, fever, general malaise, fatigue, muscle or joint aches, blisters, peeling of the skin, oral blisters, lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, difficulty breathing, hepatitis B reactivation, life-threatening reaction, death"
12,TAFINLAR,adverse reactions,"New Primary Malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, cutaneous squamous cell carcinoma, cuSCC, cough, constipation, nasopharyngitis, hypophosphatemia, increased alkaline phosphatase, hyponatremia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, increased GGT, hypoalbuminemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT Prolongation"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, KRAS mutation-positive pancreatic adenocarcinoma, recurrent NRAS mutation-positive colorectal carcinoma, head and neck carcinoma, glioblastoma, Major hemorrhagic events, Deep vein thrombosis, pulmonary embolism, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, fever, hypotension, rigors or chills, dehydration, renal failure, death"
14,HORIZANT,adverse reactions,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, breast enlargement, gynecomastia, elevated creatine kinase"
15,HORIZANT,warnings and precautions,"driving impairment, somnolence, sedation, dizziness, suicidal thoughts, behaviors, fatigue, asthenia, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), multiorgan hypersensitivity, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, withdrawal seizure, pancreatic acinar cell adenoma, carcinoma, tumors (breast, brain, lung, adrenal, non-Hodgkin's lymphoma, endometrial carcinoma in situ), death"
16,IMBRUVICA,adverse reactions,"Hemorrhage, Infections, Cytopenias, Atrial Fibrillation, Second Primary Malignancies, Tumor Lysis Syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, renal failure, creatinine increased, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, headache, hyperuricemia, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, stomatitis, dyspepsia, sinusitis, urinary tract infection, chills, anxiety, insomnia, hypertension, laceration, contusion, vision blurred, gastroesophageal reflux disease, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, death"
17,IMBRUVICA,warnings and precautions,"hemorrhage, bleeding, fatal bleeding events, Grade 3 or higher bleeding events, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, infections, fever, non-fatal infections, Grade 3 or greater infections, progressive multifocal leukoencephalopathy (PML), cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, arrhythmic symptoms, palpitations, lightheadedness, new onset dyspnea, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, malformations, reduced fetal weights, death"
18,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, hepatic failure, jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior, aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, death."
19,ULORIC,warnings and precautions,"gout flare, cardiovascular thromboembolic events, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes, hepatic failure, fatal hepatic failure, transaminase elevations, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, severe drug-induced liver injury, death"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, death"
21,CIMZIA,boxed warnings,"serious infections, hospitalization, death, active tuberculosis, reactivation of latent tuberculosis, disseminated tuberculosis, extrapulmonary tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, sepsis, lymphoma, malignancies"
22,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, malignancies, heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, tuberculosis, opportunistic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, hospitalization, death, congestive heart failure, hypersensitivity reactions, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, hepatosplenic T-cell lymphoma, acute leukemia, chronic leukemia, central nervous system demyelinating disease, multiple sclerosis, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, optic neuritis, peripheral neuropathy, aplastic anemia, leukopenia, thrombocytopenia, bruising, bleeding, pallor, autoantibodies, immunosuppression"
23,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne, musculoskeletal chest pain, myalgia, aspartate aminotransferase increased, blood glucose increased, hepatic enzyme increased"
24,KALYDECO,warnings and precautions,"elevated transaminases, ALT elevations, AST elevations, transaminase elevations, increased transaminase levels, non-congenital lens opacities, cataracts"
25,FULYZAQ,adverse reactions,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
26,FULYZAQ,warnings and precautions,worsening of infectious diarrhea
27,QUTENZA,adverse reactions,"application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
28,QUTENZA,warnings and precautions,"coughing, sneezing, irritation of eyes, irritation of airways, transient increases in blood pressure, procedural pain, acute pain, increases in blood pressure, adverse cardiovascular effects"
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Capillary Leak Syndrome, Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia"
30,GRANIX,warnings and precautions,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), Allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, Capillary Leak Syndrome (CLS), hypotension, hypoalbuminemia, edema, hemoconcentration, death"
31,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption), death"
32,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, cardiac arrhythmias, bradycardia, severe cardiac disease, sudden death, electrolyte imbalance, decreased exposure to lumefantrine, decreased efficacy, decreased bile production, increased concentrations of artemether and/or lumefantrine, loss of antimalarial efficacy, reduced effectiveness of hormonal contraceptives, increased risk of adverse effects, recrudescence, hepatic impairment, renal impairment, relapsing malaria, death"
33,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, asthenia, rash, dysarthria, diarrhea, constipation, abdominal pain, gastritis, gait disturbance, peripheral edema, urinary tract infections, fall, balance disorder, memory impairment, nystagmus, depression, insomnia, cough, hypertension, decreases in hemoglobin, decreases in hematocrit, increases in total cholesterol, increases in triglycerides, increases in LDL, increases in creatine phosphokinase"
34,APTIOM,warnings and precautions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, Withdrawal of APTIOM, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), Multiorgan Hypersensitivity, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, fever, rash, lymphadenopathy, seizures, severe nausea/vomiting, dehydration, severe gait instability, injury, hypochloremia, ataxia, vertigo, balance disorder, gait disturbance, nystagmus, abnormal coordination, asthenia, malaise, hypersomnia, sedation, lethargy, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, diplopia, blurred vision, impaired vision, elevated transaminases, jaundice, decreases in serum T3 and T4, death"
35,PROLIA,adverse reactions,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, constipation, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, pancreatitis, new malignancies, cataracts, drug-related hypersensitivity reactions, anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe musculoskeletal pain, marked elevation in serum PTH, death"
36,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, hospitalization, dermatologic reactions, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover, hypotension, dyspnea, throat tightness, facial and upper airway edema, pruritus, urticaria, marked elevations of serum parathyroid hormone (PTH), infections of the abdomen, urinary tract infections, ear infections, endocarditis, opportunistic infections, epidermal and dermal adverse events, incapacitating bone pain, incapacitating joint pain, incapacitating muscle pain, delayed fracture healing"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm, death"
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome, CRS, life-threatening, fatal, Neurological toxicities, severe, death"
39,BLINCYTO,warnings and precautions,"Infections, Effects on Ability to Drive and Use Machines, Preparation and Administration Errors, Cytokine Release Syndrome (CRS), Infusion reactions, Pyrexia, Headache, Nausea, Asthenia, Hypotension, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased total bilirubin, Disseminated intravascular coagulation (DIC), Capillary leak syndrome (CLS), Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), Neurological Toxicities, Encephalopathy, Convulsions, Speech disorders, Disturbances in consciousness, Confusion and disorientation, Coordination and balance disorders, Serious infections, Sepsis, Pneumonia, Bacteremia, Opportunistic infections, Catheter-site infections, Tumor Lysis Syndrome (TLS), Neutropenia, Febrile neutropenia, Elevated Liver Enzymes, Transient elevations in liver enzymes, Leukoencephalopathy, death."
40,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, dizziness, gastroenteritis viral, color vision changes, Non-arteritic anterior ischemic optic neuropathy (NAION), decreased vision, permanent loss of vision, death"
41,STENDRA,warnings and precautions,"hypotension, prolonged erection, priapism, penile tissue damage, permanent loss of potency, sudden loss of vision, Non Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, tinnitus, dizziness, symptomatic hypotension, lightheadedness, fainting, headache, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure"
42,XIAFLEX,adverse reactions,"tendon ruptures, serious injury to the injected extremity, corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, injection site swelling, ecchymosis, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain"
43,XIAFLEX,boxed warnings,"corporal rupture, penile fracture, serious penile injury, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound, penile ""popping"" sensation, severe penile hematoma, death"
44,XIAFLEX,warnings and precautions,"tendon rupture, serious injury to the injected finger/hand, permanent injury, ligament damage, skin laceration, corporal rupture (penile fracture), serious injury to the penis, hypersensitivity reactions, anaphylaxis, abnormal coagulation, pulley rupture, complex regional pain syndrome (CRPS), sensory abnormality of the hand, penile ecchymoses, penile hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, allergic reactions (pruritus), IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage, penile ecchymosis"
45,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, brow ptosis, sensation of pressure, blepharospasm, eye disorder, facial pain, injection site swelling, muscle disorder, elevation of eyebrow, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, death"
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, swallowing difficulties, death"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, concomitant neuromuscular disorders, exacerbate clinical effects, cervical dystonia, smaller neck muscle mass, bilateral injections, sternocleidomastoid muscles, corneal exposure, corneal ulceration, reduced blinking, ulceration, perforation, lower lid injections, diplopia, ptosis, asthenia, generalized muscle weakness, blurred vision, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, hypersensitivity reactions, anaphylaxis, serum sickness, urticaria, soft tissue edema, dyspnea, severe dysphagia, aspiration, respiratory failure, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junctional disorders, myasthenia gravis, Lambert-Eaton syndrome, severe dysphagia, respiratory compromise, persistent epithelial defect, VII nerve disorders, ectropion, narrow angle glaucoma, ecchymosis, levator palpebrae superioris, corrugator injections, supraorbital ridge, human albumin, transmission of viral diseases, Creutzfeldt-Jakob disease (CJD)"
48,GILOTRIF,adverse reactions,"Diarrhea, Bullous Skin Disorders, Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, rash/dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity/ILD-like adverse reactions, sepsis, pneumonia, dyspnea, fatigue, hypokalemia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, aphthous stomatitis, mucosal inflammation, mouth ulceration, oral mucosa erosion, mucosal erosion, mucosal ulceration, acne, acne pustular, dermatitis acneiform, nail infection, nail bed infection, cystitis, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, aspartate aminotransferase increased, cheilitis, pancreatitis, death"
49,GILOTRIF,warnings and precautions,"diarrhea, dehydration, renal failure, severe diarrhea, prolonged diarrhea, bullous skin disorders, exfoliative skin disorders, severe bullous, blistering lesions, exfoliating lesions, life-threatening cutaneous reactions, severe cutaneous reactions, prolonged cutaneous reactions, interstitial lung disease (ILD), lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, hepatic toxicity, fatal hepatic impairment, liver test abnormalities, keratitis, acute eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, embryofetal toxicity, fetal harm, abortions, death"
50,TREANDA,adverse reactions,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, mucosal inflammation, hypertension, hypertensive crisis, hypersensitivity, nasopharyngitis, infection, herpes simplex, hyperuricemia, bilirubin elevations, increased AST, increased ALT, creatinine levels changes, tachycardia, constipation, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, chills, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, weight decreased, anorexia, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, pruritus, dry skin, night sweats, hyperhidrosis, hypotension, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, dysgeusia/taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
51,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, signs of infection, anaphylaxis, infusion reactions, severe anaphylactic reactions, tumor lysis syndrome, acute renal failure, skin reactions, severe skin reactions, SJS (Stevens-Johnson syndrome), TEN (toxic epidermal necrolysis), other malignancies, pre-malignant diseases, malignant diseases, myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, extravasation injury, erythema, marked swelling, pain, necrosis, embryo-fetal toxicity, fetal harm, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights, neutropenic sepsis, diffuse alveolar hemorrhage, thrombocytopenia, pneumonia, opportunistic infection (CMV), sepsis, septic shock, fever, chills, pruritus, rash, allergic-type reactions, bullous exanthema, toxic epidermal necrolysis, Stevens-Johnson syndrome."
52,CHOLINE,adverse reactions,mild injection site reaction
53,CHOLINE,warnings and precautions,"imaging errors, blood PSA levels < 2 ng/mL, poor imaging performance, allergic reactions, anaphylaxis, radiation risk, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, interference with imaging (due to colchicine or androgen-deprivation therapeutic drugs), increased risk for cancer"
54,ERWINAZE,adverse reactions,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergic reactions, coagulopathy, hyperlipidemia, ketoacidosis, CNS events, hepatobiliary disorders, pancreatic disorders, immunogenicity, anti-drug antibodies (ADA), death"
55,ERWINAZE,warnings and precautions,"serious hypersensitivity reactions, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
56,TRULICITY,adverse reactions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, Nausea, Diarrhea, Vomiting, Abdominal pain, Decreased appetite, Dyspepsia, Fatigue, Constipation, Flatulence, Abdominal distension, Gastroesophageal reflux disease, Eructation, Heart Rate Increase, Tachycardia, Sinus tachycardia, Immunogenicity, Anti-drug antibodies, Dulaglutide-neutralizing antibodies, Hypersensitivity, Severe urticaria, Systemic rash, Facial edema, Lip swelling, Injection-site reactions, Injection-site rash, Erythema, PR Interval Prolongation, First Degree Atrioventricular Block, Amylase Increase, Lipase Increase"
57,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
58,TRULICITY,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Severe Gastrointestinal Disease, death"
59,ADREVIEW,adverse reactions,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
60,ADREVIEW,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, serious reactions, severe renal impairment, increased radiation exposure, decreased quality of scintigraphic images, benzyl alcohol toxicity, ""Gasping Syndrome"", hypotension, metabolic acidosis, kernicterus, deaths, death, false negative imaging results, withdrawal symptoms, imaging errors, thyroid neoplasia, hypertension"
61,DOTAREM,adverse reactions,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis, death"
62,DOTAREM,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, Chronic kidney disease, Acute kidney injury, reduced renal function, hypertension, diabetes, death."
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, higher than recommended dosing, repeat dosing, Hypersensitivity, Anaphylactoid reactions, anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions, death, need for emergency cardiorespiratory support, chronic severe kidney disease, chronic moderate kidney disease, chronic mild kidney disease, fatal fibrosis, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, acute kidney injury, surgery-related kidney injury, severe infection-related kidney injury, injury-related kidney injury, drug-induced kidney toxicity, rapid decrease in kidney function, reversible decrease in kidney function, estimated GFR unreliability, chronic reduced renal function, NSF risk increase, repeated GBCA doses, renal impairment, hemodialysis, circulatory collapse, bronchial asthma, allergic disorders, hypersensitivity reactions, Acute Kidney Injury, dialysis, increasing dose of contrast agent, renal impairment, renal function assessments, Extravasation, Injection Site Reactions, tissue irritation."
64,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, diarrhea, dyspepsia, nausea, upper abdominal pain, intracranial hemorrhage, hemorrhagic stroke, subarachnoid bleed, subdural bleed, gastrointestinal bleeds, major bleeding, fatal bleeding, drug hypersensitivity, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, symptomatic bleeding, intraocular bleeding, intraspinal bleeding, intramuscular bleeding with compartment syndrome, retroperitoneal bleeding, intra-articular bleeding, pericardial bleeding, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, clinical myocardial infarction, angioedema, thrombocytopenia, esophageal ulcer, death"
65,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, pathological bleeding, long-term paralysis, permanent paralysis, neurological impairment, death"
66,PRADAXA,warnings and precautions,"serious bleeding, fatal bleeding, thrombotic events, pathological bleeding, hypotension, renal impairment, epidural hematoma, spinal hematoma, paralysis, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions, hemodynamic compromise, death"
67,ELIQUIS,adverse reactions,"thrombotic events, bleeding, spinal/epidural anesthesia or puncture, hemorrhagic stroke, intracranial bleed, intracerebral hemorrhage, intraventricular hemorrhage, subdural hemorrhage, subarachnoid hemorrhage, gastrointestinal bleed, upper GI bleed, lower GI bleed, rectal bleeding, fatal bleeding, intracranial bleeding, non-intracranial bleeding, hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, hemorrhage, hematoma, vaginal hemorrhage, urethral hemorrhage, postprocedural hemorrhage, postprocedural hematoma, wound hemorrhage, vessel puncture site hematoma, catheter site hemorrhage, transaminases increased, alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, platelet count decreases, hypotension, procedural hypotension, epistaxis, gastrointestinal hemorrhage, hematemesis, melena, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, incision-site hematoma, operative hemorrhage, gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, conjunctival hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, anal hemorrhage, traumatic hematoma, periorbital hematoma, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma, death"
68,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term paralysis, permanent paralysis"
69,ELIQUIS,warnings and precautions,"serious bleeding, potentially fatal bleeding, death, increased risk of thrombotic events, stroke, bleeding, pathological bleeding, active pathological hemorrhage, epidural hematoma, spinal hematoma, long-term paralysis, permanent paralysis, neurological impairment, numbness, weakness of the legs, bowel dysfunction, bladder dysfunction"
70,ZERBAXA,adverse reactions,"Hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, dyspnea, urticaria, venous thrombosis, death"
71,ZERBAXA,warnings and precautions,"decreased efficacy, serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, death"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, death"
73,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, serious infections, death, infection"
74,FERRIPROX,warnings and precautions,"infection, fetal harm, agranulocytosis, neutropenia, death, increased ALT values, increased AST values, decreased plasma zinc concentrations"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, ALT elevations"
76,DALVANCE,warnings and precautions,"serious hypersensitivity, anaphylactic reactions, skin reactions, hypersensitivity to glycopeptides, rapid intravenous infusion reactions, Red-Man Syndrome, flushing of the upper body, urticaria, pruritus, rash, ALT elevations, liver test abnormalities, AST elevation, bilirubin elevation, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, morbidity, mortality, fluid and electrolyte imbalance, protein supplementation, surgical evaluation, development of drug-resistant bacteria"
77,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
78,ARCAPTA,boxed warnings,"asthma-related death, death"
79,ARCAPTA,warnings and precautions,"acute symptoms, cardiovascular effects, death, immediate hypersensitivity reactions, paradoxical bronchospasm, increased pulse rate, increased systolic blood pressure, increased diastolic blood pressure, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, convulsive disorders, thyrotoxicosis, sensitivity to sympathomimetic drugs, aggravation of pre-existing diabetes mellitus, aggravation of ketoacidosis, hypokalemia, hyperglycemia"
80,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
81,CERDELGA,warnings and precautions,"ECG Changes, Cardiac Arrhythmias, prolongation of the PR interval, prolongation of the QTc interval, prolongation of the QRS interval, congestive heart failure, acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia, long QT syndrome"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, death"
83,GADAVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis affecting the skin, muscle and internal organs, chronic severe kidney disease, acute kidney injury, death"
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, NSF, Anaphylactic reactions, Hypersensitivity reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Acute kidney injury, Dialysis, Extravasation, Moderate irritation, Overestimation of extent of malignant disease"
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, hemoglobin decreased, alanine transaminase increased, aspartate transaminase increased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin increased, death"
86,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, Interstitial Lung Disease (ILD), pneumonitis, QT Interval Prolongation, hyperglycemia, bradycardia, pancreatitis, embryofetal toxicity, elevations in alanine aminotransferase (ALT), jaundice, ventricular tachyarrhythmias, Torsade de pointes, sudden death, CTCAE Grade 3-4 hyperglycemia, sinus bradycardia, CTCAE Grade 3-4 elevations of lipase and/or amylase, skeletal anomalies, death"
87,XALKORI,adverse reactions,"hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, death, abdominal pain, pyrexia, weight increased, pain in extremity, muscle spasm, dizziness, headache, fatigue, neuropathy, gait disturbance, hypoaesthesia, muscular weakness, neuralgia, neuropathy peripheral, paraesthesia, peripheral sensory neuropathy, polyneuropathy, sensory disturbance, rash, renal cyst, syncope, neutropenia, lymphopenia, ALT elevation, AST elevation, hypophosphatemia, weight decreased, dyspepsia, pneumonia, acute respiratory distress syndrome, arrhythmia, respiratory failure, sepsis, hypokalemia, hepatic failure, visual impairment, photopsia, blurred vision, vitreous floaters, sensory neuropathy, dysesthesia, burning sensation in skin."
88,XALKORI,warnings and precautions,"hepatotoxicity, fatal hepatotoxicity, death, Interstitial Lung Disease (ILD), pneumonitis, QT Interval Prolongation, bradycardia, Severe Visual Loss, Embryofetal Toxicity, elevated transaminases, liver testing abnormalities, Grade 3 or 4 ILD, fatal ILD, QTcF greater than or equal to 500 ms, increase from baseline QTcF greater than or equal to 60 ms, Torsade de pointes, polymorphic ventricular tachycardia, symptomatic bradycardia, heart rate less than 50 beats per minute, Grade 3 syncope, severe visual loss, optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity"
89,BEPREVE,adverse reactions,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, swelling of tongue, swelling of throat"
90,BEPREVE,warnings and precautions,"contamination, contact lens-related irritation"
91,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, high platelet counts, high WBC counts, rash, pruritus, angioedema"
92,EDARBI,boxed warnings,"fetal toxicity, injury, death"
93,EDARBI,warnings and precautions,"fetal toxicity, fetal renal function reduction, fetal and neonatal morbidity, death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, symptomatic hypotension, transient hypotensive response, impaired renal function, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
94,POTIGA,adverse reactions,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
95,POTIGA,boxed warnings,"retinal abnormalities, vision loss, abnormal visual acuity, decreased visual acuity, damage to the photoreceptors, retinal pigmentary abnormalities, vision changes"
96,POTIGA,warnings and precautions,"urinary retention, skin discoloration, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts or behaviors, retinal abnormalities, potential vision loss, perivascular pigmentation, retinal pigment epithelium clumping, abnormal visual acuity, retinal dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, abnormal fluorescein angiography, diminished sensitivity on visual field testing, hydronephrosis, renal function impairment, urinary hesitation, dysuria, blue skin discoloration, grey-blue skin discoloration, brown skin discoloration, nail discoloration, lip discoloration, mucous membrane discoloration, palate discoloration, scleral discoloration, conjunctiva discoloration, psychosis, withdrawal seizures"
97,TUDORZA,adverse reactions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, death"
98,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, bronchospasm, anaphylaxis, urticaria, rash, itching, eye pain, discomfort, blurred vision, visual halos, colored images, red eyes, conjunctival congestion, corneal edema, difficulty passing urine, painful urination"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, vitamin D deficiency, febrile neutropenia, pain in extremity, dyspnea, dizziness, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, Thrombotic microangiopathy with acute renal failure"
100,PROMACTA,boxed warnings,hepatic decompensation
101,PROMACTA,warnings and precautions,"Hepatotoxicity, Portal vein thrombosis, Hepatic decompensation, Ascites, Encephalopathy, Liver enzyme elevations, Serum ALT increase, Serum AST increase, Bilirubin increase, Indirect hyperbilirubinemia, Clinical symptoms of liver injury, Thrombotic event, Thromboembolic complication, Venous event, Arterial event, Factor V Leiden, ATIII deficiency, Antiphospholipid syndrome, Chronic liver disease, Thrombotic complications, Abdominal pain, Nausea, Vomiting, Diarrhea, Cataracts"
102,INLYTA,adverse reactions,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia"
103,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), proteinuria, liver enzyme elevation, fetal harm, death"
104,NORTHERA,adverse reactions,"Supine Hypertension, Hyperpyrexia, Confusion, Ischemic Heart Disease, Arrhythmias, Congestive Heart Failure, Headache, Dizziness, Nausea, Hypertension, Fatigue, Increased Blood Pressure, Falls, Urinary Tract Infections, Syncope"
105,NORTHERA,boxed warnings,supine hypertension
106,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular risk, hyperpyrexia, confusion, exacerbation of ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions, bronchial asthma, aspirin hypersensitivity, death"
107,JARDIANCE,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased low-density lipoprotein cholesterol (LDL-C), urinary tract infection, female genital mycotic infections, upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, nausea, thirst, volume depletion, dehydration, hypovolemia, orthostatic hypotension, syncope, polyuria, pollakiuria, nocturia, serum creatinine increase, eGFR decrease, hypoglycemic events, severe hypoglycemic events, vaginal mycotic infection, vaginal infection, genital infection fungal, vulvovaginal candidiasis, vulvitis, phimosis, asymptomatic bacteriuria, cystitis, chronic urinary tract infections, recurrent urinary tract infections, increase in hematocrit, blood pressure (ambulatory) decreased, blood pressure systolic decreased, diabetic nephropathy, retinopathy, neuropathy, diabetic microvascular complications, balanoposthitis, balanitis, scrotal abscess, penile infection, pollakiuria, nocturia, cervicitis, urogenital infection fungal, vaginitis bacterial, balanitis candida, genitourinary tract infection"
108,JARDIANCE,warnings and precautions,"hypotension, renal impairment, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation."
110,FANAPT,boxed warnings,"increased mortality, death, cardiovascular events, heart failure, sudden death, infectious events, pneumonia"
111,FANAPT,warnings and precautions,"death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, Hyperglycemia, diabetes mellitus, Dyslipidemia, Weight Gain, Seizures, Orthostatic hypotension, dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive impairment, motor impairment, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure changes, diaphoresis, cardiac dysrhythmia, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, polydipsia, polyuria, polyphagia, weakness, cholesterol alterations, LDL alterations, HDL alterations, Triglycerides alterations, Hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, body temperature regulation disruption, Dysphagia, aspiration pneumonia, somnolence, sedation."
112,TANZEUM,adverse reactions,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, Vomiting, Gastroesophageal reflux disease, Dyspepsia, Constipation, Injection site hematoma, Injection site erythema, Injection site rash, Injection site hypersensitivity, Injection site hemorrhage, Injection site pruritus, Pneumonia, Atrial fibrillation, Atrial flutter, Appendicitis, Immunogenicity, Liver Enzyme Abnormalities, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
113,TANZEUM,boxed warnings,"thyroid C-cell tumors, carcinogenicity, medullary thyroid carcinoma (MTC), dysphagia, dyspnea, persistent hoarseness"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Macrovascular Outcomes, Carcinogenicity, Thyroid C-cell tumors (adenomas or carcinomas), MTC (medullary thyroid carcinoma), Thyroid tumors, Acute Pancreatitis, Severe abdominal pain, Vomiting, Serious hypersensitivity reaction, Pruritus, Rash, Dyspnea, Acute renal failure, Worsening of chronic renal failure, Nausea, Diarrhea, Dehydration"
115,EYLEA,adverse reactions,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, Ocular hyperemia, Corneal epithelium defect, Detachment of the retinal pigment epithelium, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, Injection site hemorrhage, Eyelid edema, Corneal edema, hypersensitivity, retinal detachment, retinal tear, endophthalmitis, immunogenicity"
116,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death"
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, death, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, peripheral edema, back pain, muscle spasms, dizziness, headache, dysuria, hypotension, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, gastritis, intestinal obstruction."
118,JEVTANA,boxed warnings,"neutropenia, neutropenic deaths, death, hypersensitivity, generalized rash, erythema, hypotension, bronchospasm, severe hypersensitivity reactions"
119,JEVTANA,warnings and precautions,"bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, anemia, thrombocytopenia, pancytopenia, neutropenic deaths, sepsis, septic shock, hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, nausea, vomiting, diarrhea, mortality related to diarrhea, gastrointestinal hemorrhage, perforation, neutropenic enterocolitis, renal failure, death, fetal harm, embryotoxic, fetotoxic, abortifacient, death due to gastrointestinal hemorrhage, death due to gastrointestinal perforation, death due to neutropenic enterocolitis, death due to renal failure, death not related to disease progression."
120,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), death"
121,YERVOY,boxed warnings,"immune-mediated adverse reactions, severe immune-mediated adverse reactions, fatal immune-mediated adverse reactions, enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy, death"
122,YERVOY,warnings and precautions,"severe immune-mediated reactions, fatal immune-mediated reactions, moderate immune-mediated adverse reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated enterocolitis, diarrhea, fever, ileus, peritoneal signs, intestinal perforation, complications, severe enterocolitis, moderate enterocolitis, hepatotoxicity, AST elevations, ALT elevations, total bilirubin elevations, hepatic failure, liver function test abnormalities, immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic manifestations, bullous manifestations, hemorrhagic manifestations, moderate dermatitis, pruritus, immune-mediated neuropathies, Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, motor neuropathy, sensory neuropathy, paresthesia, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, hypophysitis, mental status changes, abdominal pain, unusual bowel habits, hypotension, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy, encephalitis, myositis, polymyositis, ocular myositis, death"
123,FARXIGA,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in low-density lipoprotein cholesterol (LDL-C), bladder cancer, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, increase in low-density lipoprotein cholesterol (LDL)"
124,FARXIGA,warnings and precautions,"hypotension, impaired renal function, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer"
125,PICATO,adverse reactions,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
126,PICATO,warnings and precautions,"eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, severe eye pain, local skin reactions, vesiculation/pustulation, erosion/ulceration, erythema, crusting, swelling, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis"
127,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, Blood pressure increased, Dry mouth, Vomiting, Fatigue, Chills, Feeling jittery, Decreased appetite, Tremor, Disturbance in attention, Insomnia, Nervousness, Abnormal dreams, Urinary hesitation, Yawning, Vision blurred, Mydriasis, Vertigo, Tinnitus, Dysgeusia, Hot flush, Anorgasmia, Libido decreased, Orgasm abnormal, Ejaculation delayed, Erectile dysfunction, Ejaculation disorder, Ejaculation failure, Sexual dysfunction, Tachycardia, Asthenia, Weight increased, liver function test abnormal, blood prolactin increased, Musculoskeletal stiffness, Syncope, convulsion, dystonia, Depersonalization, bruxism, Urinary retention, Rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, Proteinuria, Sustained hypertension, Orthostatic hypotension, Stevens-Johnson syndrome, death"
128,PRISTIQ,boxed warnings,"suicidal thoughts, behaviors, worsening, emergence of suicidal thoughts, emergence of suicidal behaviors"
129,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, Serotonin Syndrome, Elevated Blood Pressure, hypertension, Abnormal Bleeding, bleeding events, NSAIDs, aspirin, drugs that affect coagulation, Angle Closure Glaucoma, Activation of Mania/Hypomania, Bipolar Disorder, mania, hypomania, Discontinuation Syndrome, discontinuation symptoms, Seizure, seizure disorder, Hyponatremia, SIADH, Interstitial Lung Disease, Eosinophilic Pneumonia, dyspnea, cough, chest discomfort, suicidality, unusual changes in behavior, suicidal ideation, suicidal thinking, suicidal behavior, suicidality risk, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, psychomotor restlessness, mental status changes, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, gastrointestinal symptoms, nausea, vomiting, diarrhea, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, pupillary dilation, angle closure attack, major affective disorder, dizziness, headache, irritability, insomnia, diarrhea, anxiety, fatigue, abnormal dreams, hyperhidrosis, dysphoric mood, sensory disturbances, paresthesia, electric shock sensations, confusion, headache, lethargy, emotional lability, hypomania, tinnitus, seizures, progressive dyspnea, cough, chest discomfort, death"
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, Skin discoloration, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Hematuria, Proteinuria, serum creatinine increase, estimated creatinine clearance decrease, Bone Mineral Density decrease, bone fractures, ALT abnormalities, alkaline phosphatase abnormalities, bilirubin abnormalities, serum glucose abnormalities, glycosuria, neutrophils abnormalities, fasting cholesterol abnormalities, fasting triglycerides abnormalities, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia, death"
131,STRIBILD,boxed warnings,"lactic acidosis, severe hepatomegaly with steatosis, fatal cases, severe acute exacerbations of hepatitis B, death"
132,STRIBILD,warnings and precautions,"new onset or worsening renal impairment, acute renal failure, Fanconi syndrome, lactic acidosis, severe hepatomegaly with steatosis, death, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, renal impairment, proximal renal tubular dysfunction, renal replacement therapy, bone pain, pain in extremities, fractures, muscular pain or weakness, bone mineral density (BMD) decreases, biochemical markers of bone metabolism increase, serum parathyroid hormone levels increase, 1.25 Vitamin D levels increase, osteomalacia, arthralgias, muscle pain, hypophosphatemia, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
133,NULOJIX,adverse reactions,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, hypotension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, abdominal pain upper, hypophosphatemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, hypotension, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, death"
134,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder (PTLD), central nervous system involvement, malignancies, serious infections, increased susceptibility to infection, graft loss, death"
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), neurological signs and symptoms, cognitive signs and symptoms, behavioral signs and symptoms, Other malignancies, skin malignancies, Progressive Multifocal Leukoencephalopathy (PML), serious infections, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, Polyoma virus-associated nephropathy (PVAN), kidney graft loss, acute rejection, graft loss, corticosteroid minimization, live vaccine use, death"
136,LUMIZYME,adverse reactions,"hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, edema peripheral, rash papular, flu-like illness, arthralgia, pain, recurrent reactions, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, death"
137,LUMIZYME,boxed warnings,"anaphylaxis, hypersensitivity, immune-mediated reactions, cardiorespiratory failure, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload"
138,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, chest discomfort, chest pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension, increased blood pressure, flushing, feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, immune-mediated reactions, necrotizing skin lesions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, acute cardiorespiratory failure, cardiac hypertrophy, fluid overload, ventricular arrhythmias, bradycardia, sudden cardiac death, cardiac resuscitation, defibrillation, immunogenicity, reduced clinical efficacy, loss of motor function, ventilator dependence, death"
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, Nausea, Headache, Feeling hot, Dizziness, Back pain, Vomiting, Blood pressure increased, Injection site reactions, Dysgeusia, Paresthesia, Flushing, Parosmia, Pruritus, Rash, Respiratory disorders, Fatigue, Chest pain, Vertigo, Dry mouth, Chills, Feeling abnormal, Tremor, Akathisia, Bundle branch block, Palpitation, Oral discomfort, Salivary hypersecretion, Maculopapular rash, Hyperhidrosis, Discomfort, Malaise, Elevation of serum iron values, Elevation of serum bilirubin, Anaphylactic shock, Hypotension, Pharyngolaryngeal edema, Urticaria, Face edema, Rhinitis, Conjunctivitis, Abdominal pain, Hypoesthesia, Sneezing, Cough, Pallor, Tachycardia, Restlessness, Death"
140,EOVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, death, Chronic, severe kidney disease, Acute kidney injury, reduced renal function, hypertension, diabetes"
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, higher than recommended dosing, repeated dosing, Hypersensitivity, anaphylactoid reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions, shock, chronic severe kidney disease, acute kidney injury, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, death, rapid decrease in kidney function, surgery-related kidney injury, severe infection-related kidney injury, injury-related kidney injury, drug-induced kidney toxicity, chronically reduced renal function, Anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions, shock, hypersensitivity reaction, bronchial asthma, allergic disorders, acute kidney injury, dialysis, dual excretory pathways, Extravasation, local tissue reactions, intramuscular administration, myocyte necrosis, inflammation, Serum iron determination interference, complexometric methods, falsely high iron values, falsely low iron values, caloxetate trisodium excipients, Visualization of Liver Lesions interference, severe renal failure, severe hepatic failure, elevated serum ferritin levels, high serum bilirubin, reduced hepatic contrast."
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, death, hepatic failure, febrile neutropenia, ventricular fibrillation."
143,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, serious infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, teratogenicity, embryo-fetal lethality, nausea, vomiting, diarrhea, death"
144,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, diarrhea, vomiting, dry mouth, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, death"
145,VICTRELIS,warnings and precautions,"embryofetal toxicity, birth defects, fetal death, death, anemia, decrease in hemoglobin concentrations, neutropenia, worsening of neutropenia, hypersensitivity, serious acute hypersensitivity reactions, urticaria, angioedema, dyspnea, exertional dyspnea, dizziness, syncope, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, pancytopenia"
146,VIMIZIM,adverse reactions,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, immunogenicity, anti-drug antibodies, neutralizing antibodies"
147,VIMIZIM,boxed warnings,"anaphylactic reactions, anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, hypersensitivity reactions, acute respiratory illness, serious acute exacerbation of respiratory compromise, death"
148,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, death, acute respiratory complications, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, sleep apnea, spinal or cervical cord compression (SCC), back pain, paralysis of limbs, urinary incontinence, fecal incontinence"
149,SIRTURO,adverse reactions,"Increased mortality, death, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, Transaminases Increased, rash, Blood Amylase Increased"
150,SIRTURO,boxed warnings,"increased mortality, death, QT prolongation, significant ventricular arrhythmia"
151,SIRTURO,warnings and precautions,"QT prolongation, significant ventricular arrhythmia, QTcF interval > 500 ms, Hepatotoxicity, liver injury, Increased Mortality, death, Clinically significant ventricular arrhythmia, syncope, hepatotoxic drugs, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, total bilirubin elevation, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, hypokalemia, hypocalcemia, hypomagnesemia"
152,NEURACEQ,adverse reactions,"erythema, irritation, pain"
153,NEURACEQ,warnings and precautions,"Image interpretation errors, false positives, long-term cumulative radiation exposure, increased risk of cancer, unintentional radiation exposure, errors in estimation of brain neuritic beta-amyloid plaque density, errors due to severe brain atrophy, errors due to motion artifacts, image distortion."
154,COMETRIQ,adverse reactions,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased levels of thyroid stimulating hormone (TSH), arthralgia, muscle spasms, musculoskeletal chest pain, dysgeusia, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, hair color changes, depigmentation, graying, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia, death."
155,COMETRIQ,boxed warnings,"perforations, fistulas, hemorrhage, hemoptysis, gastrointestinal hemorrhage, severe hemorrhage, death"
156,COMETRIQ,warnings and precautions,"myocardial infarction, cerebral infarction, arterial thromboembolic events, wound dehiscence, complications requiring medical intervention, hypertension, hypertensive crisis, osteonecrosis of the jaw, Palmar-plantar Erythrodysesthesia syndrome (PPES), Proteinuria, nephrotic syndrome, Reversible posterior leukoencephalopathy syndrome (RPLS), Gastrointestinal perforations, fistulas, tracheal/esophageal fistulas, hemorrhage, hemoptysis, venous thromboembolism, arterial thromboembolism, wound complications, treatment-emergent hypertension, severe hypertension, jaw pain, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration, erosion, slow healing of the mouth or jaw, intolerable Grade 2 PPES, Grade 3-4 PPES, seizures, headache, visual disturbances, confusion, altered mental function, death"
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, Infections, Angioedema, Oral ulceration, Renal failure, Impaired wound healing, Stomatitis, Rash, Fatigue, Diarrhea, Edema, Abdominal pain, Nausea, Fever, Asthenia, Cough, Headache, Decreased appetite, Hypercholesterolemia, Hyperglycemia, Increased aspartate transaminase (AST), Anemia, Leukopenia, Thrombocytopenia, Lymphopenia, Increased alanine transaminase (ALT), Hypertriglyceridemia, Hyperglycemia, Lymphopenia, Anemia, Decreased potassium, Increased AST, Increased ALT, Thrombocytopenia, Death, Dyspnea, Pneumonitis, Diarrhea, Hyperglycemia, Alkaline phosphatase increased, Bicarbonate decreased, Increased AST, Neutropenia, Potassium decreased, Hemoglobin decreased, Hyperglycemia, Cholesterol increased, AST increased, ALT increased, Triglycerides increased, Albumin decreased, Creatinine increased, Asthenia, Edema (general and peripheral), Fever, Nasopharyngitis/rhinitis/URI, Urinary tract infection, Weight decreased, Diabetes mellitus, Arthralgia, Back pain, Pain in extremity, Muscle spasms, Headache/migraine, Dysgeusia, Dizziness, Insomnia, Cough/productive cough, Epistaxis, Dyspnea/dyspnea exertional, Pneumonitis, Oropharyngeal pain, Nail disorders, Pruritus/pruritus generalized, Dry skin/xeroderma, Hypertension, Hemoglobin decreased, Lymphocytes decreased, Platelets decreased, WBC decreased, Neutrophils decreased, Alkaline phosphatase increased, Glucose (fasting) increased, Cholesterol increased, Bicarbonate decreased, AST increased, ALT increased, Phosphate decreased, Triglycerides increased, Calcium decreased, Potassium decreased, Sodium decreased, Albumin decreased, Bilirubin increased, Potassium increased, Stomatitis, Infections, Asthenia, Fatigue, Cough, Diarrhea, Dyspnea, Dehydration, Pneumonitis, Abdominal pain, Anemia, Hypercholesterolemia, Hypertriglyceridemia, Hyperglycemia, Lymphopenia, Increased creatinine, Hypophosphatemia, Hypercholesterolemia, Nausea, Pain in extremity, Insomnia, Pneumonia, Epistaxis, Hypersensitivity, Increased blood luteinizing hormone (LH) levels, Increased blood follicle stimulating hormone (FSH) levels, Ovarian cyst, Angioedema, Amenorrhea, Menorrhagia, Menstrual irregularities, Vaginal hemorrhage, Abdominal pain, Dry mouth, Hemorrhoids, Dysphagia, Impaired wound healing, Pleural effusion, Pharyngolaryngeal pain, Rhinorrhea, Hand-foot syndrome (reported as palmar-plantar erythrodysesthesia syndrome), Nail disorder, Erythema, Onychoclasis, Skin lesion, Acneiform dermatitis, Exacerbation of pre-existing diabetes mellitus, New onset of diabetes mellitus, Insomnia, Dizziness, Paresthesia, Eyelid edema, Conjunctivitis, Hypertension, Deep vein thrombosis, Renal failure, Tachycardia, Congestive cardiac failure, Jaw pain, Hemorrhage, Acute pancreatitis, Cholecystitis, Cholelithiasis, Arterial thrombotic events, Reflex sympathetic dystrophy."
158,AFINITOR,warnings and precautions,"non-infectious pneumonitis, fatal cases, infections, fatal, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, death, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, laboratory test alterations, elevations of serum creatinine, urinary protein, blood glucose, lipids, decreases in hemoglobin, neutrophils, platelets, vaccinations, embryo-fetal toxicity, fetal harm, pneumonia, mycobacterial infections, bacterial infections, invasive fungal infections, aspergillosis, candidiasis, pneumocystis jiroveci pneumonia (PJP), viral infections, hepatitis B virus reactivation, sepsis, respiratory failure, hepatic failure, hypoxia, pleural effusion, cough, dyspnea, opportunistic infections, hyperglycemia, hyperlipidemia, hypertriglyceridemia, decreased hemoglobin, lymphocytes, neutrophils, platelets, drug-drug interactions, hepatic impairment, live vaccines."
159,BREO,adverse reactions,"asthma-related death, death, hospitalization, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, Candida albicans infection, pneumonia, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, oropharyngeal candidiasis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
160,BREO,boxed warnings,"asthma-related death, increase in asthma-related deaths, asthma-related hospitalization, death"
161,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, overdose, Candida albicans infection, pneumonia, worsening of infections, tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, chickenpox, measles, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, death"
162,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
163,FIRAZYR,warnings and precautions,"laryngeal attacks, airway obstruction"
164,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), female genital mycotic infections, urinary tract infection, increased urination, male genital mycotic infections, Vulvovaginal pruritus, Thirst, Constipation, Nausea, Abdominal pain, fatigue, loss of strength or energy, asthenia, pancreatitis, erythema, rash, pruritus, urticaria, angioedema, Photosensitivity reactions, photosensitivity reaction, polymorphic light eruption, sunburn, Volume Depletion-Related Adverse Reactions, hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration, Falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, vulvovaginal mycotic infection, vulvovaginal candidiasis, vulvovaginitis, candidal balanitis, balanoposthitis, phimosis, circumcision, Severe hypoglycemia, Increases in Serum Potassium, Increases in Serum Magnesium, Increases in Serum Phosphate, Increases in Low-Density Lipoprotein Cholesterol (LDL-C), non-High-Density Lipoprotein Cholesterol (non-HDL-C), Increases in Hemoglobin, Decreases in Bone Mineral Density, BMD declines at the total hip, lumbar spine, femoral neck, distal forearm"
165,INVOKANA,warnings and precautions,"hypotension, volume contraction, symptomatic hypotension, impaired renal function, renal function abnormalities, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, generalized urticaria, bone fracture, increased LDL-C"
166,VORAXAZE,adverse reactions,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
167,VORAXAZE,warnings and precautions,"serious allergic reactions, anaphylactic reactions, erroneous measurement"
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
169,NESINA,warnings and precautions,"acute pancreatitis, hypersensitivity reactions, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, death, hypoglycemia, arthralgia, severe and disabling arthralgia, liver injury, liver enzyme elevations, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice."
170,GILENYA,adverse reactions,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy, Macular Edema, Posterior Reversible Encephalopathy Syndrome, Respiratory Effects, Liver Injury, Headache, Liver transaminase elevation, Diarrhea, Cough, Influenza, Sinusitis, Back pain, Abdominal pain, Pain in extremity, Serum transaminase elevations, Basal cell carcinoma, Influenza, Sinusitis, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Migraine, Nausea, Asthenia, Alopecia, Actinic keratosis, Blood triglycerides increased, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, Dizziness, Pneumonia, Eczema, Pruritus, Ischemic strokes, Hemorrhagic strokes, Peripheral arterial occlusive disease, Lymphomas"
171,GILENYA,warnings and precautions,"bradycardia, atrioventricular conduction, infections, progressive multifocal leukoencephalopathy (PML), macular edema, posterior reversible encephalopathy syndrome (PRES), decrease in pulmonary function tests (PFT), liver injury, blood pressure (BP) increase, bradyarrhythmia, atrioventricular blocks, AV conduction delays, first-degree AV block, second-degree AV block, Mobitz Types I (Wenckebach), 2:1 AV blocks, third-degree AV block, AV block with junctional escape, asystole, death, syncope, lymphocyte count reduction, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, herpetic infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus (VZV) infection, JC virus (JCV) infection, hypotension, dizziness, fatigue, palpitations, chest pain, visual disturbances, blurred vision, decreased visual acuity, forced expiratory volume over 1 second (FEV1) reduction, diffusion lung capacity for carbon monoxide (DLCO) reduction, dyspnea, liver transaminases elevation, jaundice, dark urine, fetal harm, systolic pressure increase, diastolic pressure increase, hypertension, lymphocyte count normalization delay, immune system effects after discontinuation."
172,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, cytopenias, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death"
173,HALAVEN,warnings and precautions,"neutropenia, severe neutropenia, Grade 4 neutropenia, febrile neutropenia, peripheral neuropathy, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, embryo-fetal toxicity, teratogenicity, QT prolongation, hypokalemia, hypomagnesemia"
174,INTELENCE,adverse reactions,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, toxic epidermal necrolysis, death"
175,INTELENCE,warnings and precautions,"severe skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 rashes, Grade 4 rashes, fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, death, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
176,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
177,AMYVID,warnings and precautions,"image interpretation errors, false negatives, radiation risk, unintentional radiation exposure, errors in Amyvid estimation, misinterpretation, extensive brain atrophy, motion artifacts, increased risk of cancer"
178,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
179,ULESFIA,warnings and precautions,"neonatal toxicity, gasping syndrome, eye irritation, contact dermatitis, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death"
180,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, insomnia, back pain, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)"
181,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, weight loss, drug interactions, loss of efficacy, discontinued treatment due to depression, serious depression, suicidal ideation, suicidal behavior, attempted suicide, death"
182,ILARIS,adverse reactions,"infections, upper respiratory tract infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, abdominal pain (upper), hypersensitivity, decreased white blood cells, neutrophils, platelets, elevated transaminases, high ALT, high AST, elevated serum bilirubin"
183,ILARIS,warnings and precautions,"serious infections, increased risk of serious infections, recurring infections, predisposition to infections, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, reactivation of latent tuberculosis, opportunistic infections, immunosuppression, risk of malignancies, hypersensitivity reactions, anaphylactic reactions, impaired immune response to new antigens, ineffective vaccinations, macrophage activation syndrome (MAS), death"
184,NATAZIA,adverse reactions,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, migraines, breast pain, menstrual disorders, metrorrhagia, menorrhagia, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, abnormal withdrawal bleeding, uterine hemorrhage, vomiting, acne, mood changes, depression, mood swings, altered mood, depressed mood, dysthymic disorder, crying, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis"
185,NATAZIA,boxed warnings,serious cardiovascular events
186,NATAZIA,warnings and precautions,"thrombotic event, arterial thrombosis, venous thrombosis, venous thromboembolism (VTE), arterial thromboses, strokes, myocardial infarctions, cerebrovascular events, thrombotic strokes, hemorrhagic strokes, retinal vein thrombosis, jaundice, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, high blood pressure, gallbladder disease, glucose tolerance decrease, dyslipidemia, adverse lipid changes, hypertriglyceridemia, pancreatitis, headache, migraine, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, intracyclic bleeding, depression, hereditary angioedema, chloasma, death"
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
188,DIFICID,warnings and precautions,"acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash, drug-resistant bacteria, allergy to other macrolides"
189,ONFI,adverse reactions,"somnolence, sedation, potentiation of sedation, central nervous system depressants, withdrawal symptoms, serious dermatological reactions, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, constipation, pyrexia, lethargy, drooling, ataxia, aggression, fatigue, insomnia, vomiting, dysphagia, irritability, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, psychomotor hyperactivity, dysarthria, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial edema, lip edema"
190,ONFI,warnings and precautions,"somnolence, sedation, CNS depression, withdrawal symptoms, serious dermatological reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, dysphoria, insomnia, depression, mood changes, thoughts about self-harm, death"
191,TECFIDERA,adverse reactions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albuminuria, erythema, dyspepsia, increased aspartate aminotransferase, increased alanine aminotransferase, eosinophilia"
192,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, difficulty breathing, urticaria, swelling of the throat, swelling of the tongue, Progressive multifocal leukoencephalopathy (PML), death, lymphopenia, prolonged lymphopenia, infections, serious infections, progressive weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory changes, confusion, personality changes, flushing, warmth, redness, itching, burning sensation"
193,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity and accommodation, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, breathing difficulties, dyspnea, laboratory findings, electrocardiographic findings, heart rate reduction, blood glucose increase, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, numbness, discomfort, erythema, tenderness, tingling, itching, stinging, warmth, irritation, tightness, swelling, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, excessive granulation tissue, gait disturbance, hypertonia, sensation of heaviness."
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
195,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, exacerbation of clinical effects, transmission of Creutzfeldt-Jakob disease (CJD), asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, severe dysphagia, aspiration, weakening of neck muscles, respiratory failure, surgical alterations to facial anatomy, excessive weakness, atrophy, marked facial asymmetry, inflammation, eyelid ptosis, excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, myasthenia gravis, Lambert-Eaton syndrome, severe dysphagia, respiratory compromise, immune reaction, intradermal immune reaction"
196,ZYTIGA,adverse reactions,"Hypertension, Hypokalemia, Fluid Retention, Mineralocorticoid Excess, Adrenocortical Insufficiency, Hepatotoxicity, Fatigue, Joint Swelling, Discomfort, Edema, Hot Flush, Diarrhea, Vomiting, Cough, Dyspnea, Urinary Tract Infection, Contusion, Anemia, Elevated Alkaline Phosphatase, Hypertriglyceridemia, Lymphopenia, Hypercholesterolemia, Hyperglycemia, Elevated AST, Hypophosphatemia, Elevated ALT, Muscle Discomfort, Dyspepsia, Upper Respiratory Tract Infection, Urinary Frequency, Nocturia, Fractures, Arrhythmia, Chest Pain, Chest Discomfort, Cardiac Failure, Pyrexia, Groin Pain, Constipation, Insomnia, Falls, Nasopharyngitis, Hematuria, Rash, Hypernatremia, Non-infectious Pneumonitis, Myopathy, Rhabdomyolysis, Death"
197,ZYTIGA,warnings and precautions,"Mineralocorticoid excess, cardiovascular disease, LVEF < 50%, NYHA Class III or IV heart failure, NYHA Class II to IV heart failure, hypertension, hypokalemia, fluid retention, edema, myocardial infarction, ventricular arrhythmia, adrenocortical insufficiency, hepatotoxicity, increases in liver enzymes, drug interruption, dose modification, discontinuation, liver function test elevation, ALT increase, AST increase, treatment discontinuation, serum transaminases elevation, bilirubin levels elevation, liver function tests abnormality."
198,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, hot flush, all-cause mortality, serious adverse reactions, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, death"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), blood clots, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, new breast lumps, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
200,DUAVEE,warnings and precautions,"cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, probable dementia, visual abnormalities, elevated blood pressure, hypertriglyceridemia, hepatic impairment, past history of cholestatic jaundice, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, exacerbation of diabetes mellitus, exacerbation of epilepsy, exacerbation of migraine, exacerbation of porphyria, exacerbation of systemic lupus erythematosus, exacerbation of hepatic hemangiomas, impaired glucose tolerance"
201,SAPHRIS,adverse reactions,"dementia-related psychosis, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hypersensitivity reactions, oral ulcers, blisters, peeling/sloughing, inflammation, orthostatic hypotension, syncope, hemodynamic effects, leukopenia, neutropenia, agranulocytosis, QT interval prolongation, hyperprolactinemia, seizures, cognitive impairment, motor impairment, body temperature regulation, suicide, dysphagia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, dysgeusia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, dyspepsia, toothache, arthralgia, pain in extremity, headache, depression, tachycardia, glossodynia, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, parkinsonism, suicidal ideation, anger, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, choking, death"
202,SAPHRIS,boxed warnings,"increased mortality, death"
203,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, hyperglycemia, dyslipidemia, weight gain, hypersensitivity reactions, anaphylaxis, angioedema, Orthostatic Hypotension, Syncope, hemodynamic effects, dizziness, tachycardia, bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Cognitive and Motor Impairment, Suicide, increased mortality, death, heart failure, sudden death, pneumonia, diabetes mellitus, ketoacidosis, hyperosmolar coma, polydipsia, polyuria, polyphagia, weakness, Hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, decreased bone density, somnolence, hypersomnia, sedation, Body Temperature Regulation, pyrexia, feeling hot, Dysphagia, aspiration pneumonia, myocardial infarction, unstable heart disease, cardiac dysrhythmia, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure changes, diaphoresis, elevated creatine phosphokinase, myoglobinuria, rhabdomyolysis, acute renal failure, systemic infection, extrapyramidal signs and symptoms, central anticholinergic toxicity, heat stroke, drug fever, primary central nervous system pathology, hypokalemia, hypomagnesemia, congenital prolongation of the QT interval, bradycardia, dehydration, hypovolemia, respiratory depression, central nervous system depression."
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal thinning, scleral thinning, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritus, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, scleral hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis"
205,DUREZOL,warnings and precautions,"Intraocular pressure increase, glaucoma, damage to the optic nerve, defects in visual acuity, defects in fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, bleb formation, corneal or scleral thinning, perforations, bacterial infections, suppression of host response, secondary ocular infections, acute purulent conditions, masking of infection, enhancement of existing infection, viral infections, prolonging the course of viral infections, exacerbation of viral infections, herpes simplex, fungal infections, corneal fungal infections, persistent corneal ulceration, fungus invasion."
206,ZYDELIG,adverse reactions,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, sepsis, febrile neutropenia, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
207,ZYDELIG,boxed warnings,"hepatic toxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, death"
208,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, death, ALT elevations, AST elevations, severe diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, serious allergic reactions, treatment-emergent Grade 3 or 4 neutropenia, teratogenic effects"
209,KALBITOR,adverse reactions,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, erythema, pain, irritation, urticaria, bruising, seroconversion, anti-ecallantide antibodies, neutralizing antibodies, loss of efficacy, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies, immunogenicity."
210,KALBITOR,boxed warnings,"anaphylaxis, hypersensitivity reactions, hereditary angioedema"
211,KALBITOR,warnings and precautions,"anaphylaxis, hypersensitivity reactions, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
212,ADCETRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, abdominal pain, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, pneumonia, hepatotoxicity, paraesthesia, acute respiratory distress syndrome, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), toxic epidermal necrolysis, death"
213,ADCETRIS,boxed warnings,"progressive multifocal leukoencephalopathy (PML), JC virus infection, death"
214,ADCETRIS,warnings and precautions,"peripheral neuropathy, neuropathy, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, anaphylaxis, infusion reactions, hematologic toxicities, neutropenia, thrombocytopenia, anemia, febrile neutropenia, serious infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, death, tumor lysis syndrome, hepatotoxicity, hepatocellular injury, elevations of transaminases, elevated bilirubin, progressive multifocal leukoencephalopathy (PML), pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), embryo-fetal toxicity, fetal harm, decreased embryo viability, fetal malformations."
215,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"Growth of Resistant Organisms with Prolonged Use, overgrowth of non-susceptible organisms, fungi, super-infection"
217,CLEVIPREX,adverse reactions,"headache, nausea, vomiting, hypotension, reflex tachycardia, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation (possible pulmonary shunting), death"
218,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbate heart failure, lipid intake restrictions, rebound hypertension"
219,XTANDI,adverse reactions,"seizure, asthenia, fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness, vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract infection, lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, sepsis, fall-related injuries, joint injuries, hematomas, hypertensive crisis, death"
220,XTANDI,warnings and precautions,seizure
221,BOSULIF,adverse reactions,"Gastrointestinal toxicity, Myelosuppression, Hepatic toxicity, Fluid retention, Renal toxicity, Diarrhea, Nausea, Thrombocytopenia, Vomiting, Abdominal pain, Rash, Anemia, Pyrexia, Fatigue, Anaphylactic shock, Increased alanine aminotransferase, Headache, Cough, Increased aspartate aminotransferase, Neutropenia, Edema, Arthralgia, Decreased appetite, Respiratory tract infection, Nasopharyngitis, Back pain, Asthenia, Pruritus, Dizziness, Dyspnea, QTcF interval prolongation, Platelet Count Low, Absolute Neutrophil Count Low, Hemoglobin Low, SGPT/ALT greater than 5.0*ULN, SGOT/AST greater than 5.0*ULN, Lipase greater than 2*ULN, Phosphorus Low, Total Bilirubin greater than 3.0*ULN, Febrile neutropenia, Pericardial effusion, Pericarditis, Tinnitus, Gastritis, Acute pancreatitis, Gastrointestinal hemorrhage, Chest pain, Chest discomfort, Pain, Hepatotoxicity, Toxic hepatitis, Cytolytic hepatitis, Abnormal hepatic function, Liver disorder, Liver injury, Drug hypersensitivity, Pneumonia, Bronchopneumonia, Lobar pneumonia, Primary atypical pneumonia, Influenza, Bronchitis, Electrocardiogram QT prolonged, Increased blood creatine phosphokinase, Increased blood creatinine, Hyperkalemia, Dehydration, Myalgia, Dysgeusia, Acute renal failure, Renal failure, Pleural effusion, Acute pulmonary edema, Respiratory failure, Pulmonary hypertension, Urticaria, Acne, Erythema multiforme, Exfoliative rash, Drug eruption."
222,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity, Diarrhea, Nausea, Vomiting, Abdominal Pain, Myelosuppression, Thrombocytopenia, Anemia, Neutropenia, Hepatic Toxicity, Drug Induced Liver Injury, ALT Elevation, AST Elevation, Transaminase Elevations, Fluid Retention, Pericardial Effusion, Pleural Effusion, Pulmonary Edema, Peripheral Edema, Renal Toxicity, Decline in eGFR, Kidney Failure, Embryofetal Toxicity, Fetal Harm"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsillitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
224,CARBAGLU,warnings and precautions,"Hyperammonemia, injury to the brain, death, brain injury/damage, acute symptomatic hyperammonemia."
225,SIMPONI,adverse reactions,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis (TB), invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, lupus-like syndrome, anti-dsDNA antibodies, infusion reactions, immunogenicity, pyrexia, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, melanoma, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions"
226,SIMPONI,boxed warnings,"serious infections, hospitalization, death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, sepsis, latent TB, active TB, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria, lymphoma, malignancies"
227,SIMPONI,warnings and precautions,"serious infections, invasive fungal infections, Hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, hypersensitivity reactions, anaphylaxis, opportunistic infections, hospitalization, death, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, chronic infection, recurrent infection, sepsis, worsening congestive heart failure, new onset congestive heart failure, central nervous system demyelinating disorders, multiple sclerosis, peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, serious infections with abatacept, serious infections with anakinra, neutropenia with anakinra, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, live vaccine infections, disseminated infections, therapeutic infectious agents infections, anaphylactic reaction, allergic reaction."
228,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, erythematous rash, pruritus, eyelid edema, headache, dyspnea, Fatal anaphylaxis, death"
229,BENLYSTA,warnings and precautions,"mortality, deaths, serious infections, fatal infections, Progressive Multifocal Leukoencephalopathy (PML), neurological signs and symptoms, Hypersensitivity Reactions, Anaphylaxis, serious reactions, fatal reactions, Depression, suicidality, worsening depression, suicidal thoughts, mood changes, live vaccines, malignancies, non-melanoma skin cancers, acute hypersensitivity reactions, rash, nausea, fatigue, myalgia, headache, facial edema, non-acute hypersensitivity reactions, infusion reactions, bradycardia, skin reactions, urticaria, hypotension, psychiatric events, depression-related events, insomnia, anxiety, serious psychiatric events, serious depression, suicides, death"
230,TOVIAZ,adverse reactions,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
231,TOVIAZ,warnings and precautions,"Angioedema, urinary retention, severe constipation, narrow-angle glaucoma, somnolence, headache, dizziness, life-threatening (death)"
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,"myocardial infarction, death"
234,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea, vomiting, diarrhea, serious adverse reactions, death"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, death"
236,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, image interpretation errors, false positives, radiation risk, cancer, motion artifacts"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, treatment emergent adverse events, discontinuation, confusional state"
238,AMPYRA,warnings and precautions,"seizures, anaphylaxis, respiratory compromise, urticaria, angioedema, urinary tract infections"
239,ADCETRIS,all-concat,"peripheral neuropathy, peripheral sensory neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, progressive multifocal leukoencephalopathy (PML), pulmonary toxicity, serious dermatologic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, embryo-fetal toxicity, neutropenia, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, abdominal pain, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), death"
240,ADREVIEW,all-concat,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, anaphylactic reactions, benzyl alcohol toxicity, hypotension, metabolic acidosis, kernicterus, increased radiation exposure, thyroid neoplasia, hypertension, death"
241,AFINITOR,all-concat,"non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, anemia, leukopenia, thrombocytopenia, lymphopenia, increased aspartate transaminase (AST), increased alanine transaminase (ALT), hypertriglyceridemia, hypercholesterolemia, hyperglycemia, increased aspartate transaminase (AST), leukopenia, thrombocytopenia, lymphopenia, increased alanine transaminase (ALT), hypertriglyceridemia, stomatitis, respiratory tract infection, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, epistaxis, decreased appetite, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, hypersensitivity, ovarian cyst, pneumonitis, angioedema, vomiting, constipation, peripheral edema, upper respiratory tract infection, arthralgia, acne, dry mouth, diarrhea, fatigue/malaise, fever, asthenia, nasopharyngitis/rhinitis/URI, urinary tract infection, weight decreased, diabetes mellitus, arthralgia, back pain, pain in extremity, muscle spasms, headache/migraine, dysgeusia, dizziness, insomnia, cough/productive cough, epistaxis, dyspnea/dyspnea exertional, pneumonitis, oropharyngeal pain, rash, nail disorders, pruritus/pruritus generalized, dry skin/xeroderma, hypertension, abdominal pain, dry mouth, hemorrhoids, dysphagia, impaired wound healing, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome (reported as palmar-plantar erythrodysesthesia syndrome), nail disorder, erythema, onychoclasis, skin lesion, acneiform dermatitis, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, insomnia, dizziness, paresthesia, eyelid edema, conjunctivitis, hypertension, deep vein thrombosis, renal failure, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, anemia, elevated partial thromboplastin time, neutropenia, hypercholesterolemia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, vomiting, diarrhea, constipation, respiratory tract infection, gastroenteritis, pharyngitis streptococcal, pyrexia, fatigue, anxiety, aggression or other behavioral disturbance, rash, acne, amenorrhea, dysmenorrhea, menorrhagia, metrorrhagia, unspecified menstrual irregularity, nausea, pain in extremity, insomnia, pneumonia, epistaxis, hypersensitivity, increased blood luteinizing hormone (LH) levels, pneumonitis, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy, death"
242,AMPYRA,all-concat,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state, renal impairment, respiratory compromise, urticaria, angioedema"
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing, image interpretation errors, radiation risk"
244,APTIOM,all-concat,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, rash, dysarthria, diarrhea, constipation, abdominal pain, gastritis, asthenia, gait disturbance, peripheral edema, urinary tract infections, fall, hypertension, depression, insomnia, cough, visual impairment, balance disorder, memory impairment, nystagmus, cognitive dysfunction, hazardous activities, withdrawal of AEDs, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, fever, lymphadenopathy, serious nausea/vomiting, severe gait instability, injury, hypochloremia, disturbance in gait and coordination, balance disorder, gait disturbance, abnormal coordination, malaise, hypersomnia, sedation, lethargy, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, impaired vision, elevated transaminases, elevated bilirubin, serum T3 decrease, serum T4 decrease"
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
246,BELEODAQ,all-concat,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, death, febrile neutropenia, leukopenia, neutropenia, lymphopenia, sepsis, liver function test abnormalities, embryo-fetal toxicity, teratogenicity, embryo-fetal lethality, genotoxicity."
247,BENLYSTA,all-concat,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, Nausea, Diarrhea, Pyrexia, Nasopharyngitis, Bronchitis, Insomnia, Pain in extremity, Migraine, Pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, Lupus nephritis, Infections, Progressive Multifocal Leukoencephalopathy (PML), Upper respiratory tract infection, Urinary tract infection, Sinusitis, Influenza, Pneumonia, Cellulitis, Erythematous rash, Pruritus, Eyelid edema, Headache, Dyspnea, Fatal anaphylaxis, Cardiovascular disease, Suicide, JC virus-associated PML, Non-melanoma skin cancers, Hypotension, Angioedema, Urticaria, Rash, Fatigue, Myalgia, Facial edema, Bradycardia, Anxiety, death"
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
250,BLINCYTO,all-concat,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, infection, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, other pathogen infections, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, capillary leak syndrome, hypersensitivity, bronchospasm, death."
251,BOSULIF,all-concat,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT elevation, SGOT/AST elevation, lipase increase, phosphorus low, total bilirubin increase, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption, embryofetal toxicity"
252,BREO,all-concat,"asthma-related death, death, asthma-related hospitalization, Candida albicans infection, pneumonia, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, arthralgia, influenza, pharyngitis, pyrexia, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, paradoxical bronchospasm, hypokalemia, hyperglycemia, decreased bone mineral content, glaucoma, increased intraocular pressure, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, growth velocity reduction"
253,CARBAGLU,all-concat,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, brain injury, death"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, cardiac arrhythmias, ECG changes, PR interval prolongation, QTc interval prolongation, QRS interval prolongation, death"
255,CHOLINE,all-concat,"injection site reaction, allergic reactions, anaphylaxis, imaging errors, blood PSA levels < 2 ng/mL associated with poor imaging performance, false positive results, false negative results, tissue inflammation associated with false positive images, radiation risk, increased risk for cancer"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, lupus-like syndrome, hepatitis B virus reactivation, demyelinating disease, cytopenias, hypersensitivity reactions, angioedema, dizziness (postural), dyspnea, hot flush, hypotension, malaise, serum sickness, syncope, hepatosplenic T-cell lymphoma, acute and chronic leukemia, death"
257,CLEVIPREX,all-concat,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation, negative inotropic effects, heart failure exacerbation, rebound hypertension, death"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, nasopharyngitis, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, aspartate aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, hypersensitivity reactions, anaphylaxis, angioedema, bullous eruption, QT prolongation, congenital prolongation of the QT interval, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, disturbances of electrolyte balance, hypokalemia, hypomagnesemia, recrudescence, hepatic impairment, renal impairment, Plasmodium vivax infection."
259,COMETRIQ,all-concat,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, asthenia, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, dysgeusia, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia, pneumonia, septicemia, cardiac arrest, respiratory failure, unspecified death, death"
260,DALVANCE,all-concat,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, serious hypersensitivity (anaphylactic) and skin reactions, Red-Man Syndrome, Clostridium difficile-associated diarrhea (CDAD), death"
261,DATSCAN,all-concat,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, skin erythema, injection site pain, anaphylactic reactions, thyroid neoplasia"
262,DIFICID,all-concat,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
263,DOTAREM,all-concat,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis, death"
264,DUAVEE,all-concat,"muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), gallbladder disease, loss of vision, high blood pressure, hypertriglyceridemia, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems, blood clots, heart attack, cancer of the lining of the uterus, breast cancer, cancer of the ovary, dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems such as asthma, diabetes, epilepsy, migraines, a genetic problem called porphyria, lupus, liver problems, new breast lumps, unusual vaginal bleeding, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, hot flush, death"
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal thinning, scleral thinning, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritus, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, scleral hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis, glaucoma, defects in visual fields, delayed healing, bleb formation, bacterial infections, viral infections, fungal infections"
266,DYSPORT,all-concat,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity and accommodation, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, asthenia, generalized muscle weakness, dysarthria, urinary incontinence, breathing difficulties, death, ptosis, dysphagia, dysphonia, dysarthria, respiratory failure, facial paresis, hypoesthesia, erythema, excessive granulation tissue, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, sensation of heaviness, gait disturbance, hypertonia, injection site reactions, pain, bruising, haemorrhage, injection site erythema/haematoma, dysphagia, gait disturbance, hypertonia, sensation of heaviness, blood glucose increase, ECG changes, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, numbness, discomfort, erythema, tenderness, tingling, itching, stinging, warmth, irritation, tightness, swelling, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, depression, immunogenicity, antibody formation, binding antibodies, neutralizing antibodies."
267,EDARBI,all-concat,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, rash, pruritus, angioedema, death"
268,ELIQUIS,all-concat,"thrombotic events, bleeding, spinal/epidural anesthesia or puncture, hemorrhagic stroke, intracranial hemorrhage, gastrointestinal bleed, fatal bleeding, intracranial bleeding, non-intracranial bleeding, hypersensitivity reactions, skin rash, anaphylactic reactions, allergic edema, syncope, hemorrhagic anemia, hypotension, procedural hypotension, epistaxis, gastrointestinal hemorrhage, hematemesis, melena, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, incision-site hematoma, operative hemorrhage, gingival bleeding, hemoptysis, muscle hemorrhage, ocular hemorrhage, conjunctival hemorrhage, rectal hemorrhage, thrombocytopenia, platelet count decreases, hemorrhoidal hemorrhage, traumatic hematoma, periorbital hematoma, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma, death"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea, vomiting, diarrhea, serious adverse reactions, death"
270,EOVIST,all-concat,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, Nausea, Headache, Feeling hot, Dizziness, Back pain, Vomiting, Blood pressure increased, Injection site reactions, Dysgeusia, Paresthesia, Flushing, Parosmia, Pruritus, Rash, Respiratory disorders, Fatigue, Chest pain, Vertigo, Dry mouth, Chills, Feeling abnormal, Tremor, Akathisia, Bundle branch block, Palpitation, Oral discomfort, Salivary hypersecretion, Maculopapular rash, Hyperhidrosis, Discomfort, Malaise, Serum iron values elevation, Serum bilirubin laboratory values elevation, Anaphylactic shock, Hypotension, Pharyngolaryngeal edema, Urticaria, Face edema, Rhinitis, Conjunctivitis, Abdominal pain, Hypoesthesia, Sneezing, Cough, Pallor, Tachycardia, Restlessness, Acute kidney injury, Extravasation, Myocyte necrosis, Inflammation, False serum iron determination, Reduced hepatic contrast, Death (due to NSF being potentially fatal as mentioned in the BOXED WARNING)."
271,ERWINAZE,all-concat,"hypersensitivity reactions, anaphylaxis, pancreatitis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, systemic hypersensitivity, hyperbilirubinemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, infarct, hyperlipidemia, ketoacidosis, CNS events, cerebral venous thrombosis, hepatobiliary disorders, pancreatic disorders"
272,EYLEA,all-concat,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased, vitreous detachment, Ocular hyperemia, Corneal epithelium defect, Detachment of the retinal pigment epithelium, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, Injection site hemorrhage, Eyelid edema, Corneal edema, hypersensitivity, retinal tear, immunogenicity, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death"
273,FANAPT,all-concat,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, death, cerebrovascular adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, Hyperglycemia, diabetes mellitus, Dyslipidemia, Seizures, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive and motor impairment, Hyperprolactinemia, Body Temperature Regulation, Dysphagia."
274,FARXIGA,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in low-density lipoprotein cholesterol (LDL-C), bladder cancer, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, increase in low-density lipoprotein cholesterol (LDL-C), death"
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, death"
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
277,FULYZAQ,all-concat,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
278,GADAVIST,all-concat,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, death, headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash, pruritus, erythema, anaphylactoid reactions, dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, acute kidney injury, extravasation"
279,GILENYA,all-concat,"bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, nausea, asthenia, alopecia, actinic keratosis, blood triglycerides increased, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphomas, bradycardia, hypotension, fatigue, palpitations, chest pain, atrioventricular conduction delays, Mobitz Types I, 2:1 AV blocks, third-degree AV block, AV block with junctional escape, transient asystole, syncope, herpetic infections, herpes zoster, herpes simplex encephalitis, disseminated varicella zoster, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus, forced expiratory volume reduction, diffusion lung capacity for carbon monoxide reduction, bronchitis, pneumonia, serum transaminase elevations, jaundice, dark urine, fetal harm, systolic pressure increase, diastolic pressure increase, immune system effects, death"
280,GILOTRIF,all-concat,"Diarrhea, Bullous Skin Disorders, Exfoliative Skin Disorders, Interstitial Lung Disease, Hepatic Toxicity, Keratitis, Rash/Dermatitis acneiform, Stomatitis, Paronychia, Dry skin, Decreased appetite, Nausea, Vomiting, Pruritus, Pulmonary toxicity, ILD-like adverse reactions, Sepsis, Pneumonia, Death, Dose reductions, Discontinuation of therapy, Ventricular dysfunction, Diastolic dysfunction, Left ventricular dysfunction, Ventricular dilation, Gastrointestinal disorders, Cheilitis, Infections and infestations, Cystitis, Metabolism and nutrition disorders, Respiratory, thoracic and mediastinal disorders, Epistaxis, Rhinorrhea, Investigations, Weight Decreased, General disorders and administration site conditions, Pyrexia, Eye disorders, Conjunctivitis, Laboratory Abnormalities, Alanine aminotransferase increased, Hypokalemia, Aspartate aminotransferase increased, Pancreatitis, Renal failure, Bullous, Blistering lesions, Exfoliating lesions, Erythema, Acneiform rash, Palmar-plantar erythrodysesthesia syndrome, Lung infiltration, Pneumonitis, Acute respiratory distress syndrome, Alveolitis allergic, Liver test abnormalities, Eye inflammation, Lacrimation, Light sensitivity, Blurred vision, Eye pain, Red eye, Embryofetal toxicity, Abortions, Contraception, Pregnancy."
281,GRANIX,all-concat,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), Serious Allergic Reactions, anaphylaxis, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle Cell Crisis, Capillary Leak Syndrome (CLS), hypotension, hypoalbuminemia, edema, hemoconcentration, Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome (acute febrile neutrophilic dermatosis), cutaneous vasculitis, thrombocytopenia, death"
282,HALAVEN,all-concat,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, death"
283,HORIZANT,all-concat,"somnolence/sedation, dizziness, RLS, PHN, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts or behaviors, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, withdrawal seizure, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, insomnia, asthenia, confusional state, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), multiorgan hypersensitivity, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, tumorigenic potential, cancer, new tumors, preexisting tumors worsened"
284,ILARIS,all-concat,"infections, upper respiratory tract infections, serious infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, abdominal pain (upper), hypersensitivity reactions, immunogenicity, decreased white blood cell counts, neutrophils, platelets, high ALT, high AST, mild elevations of serum bilirubin, opportunistic infections (e.g., aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster), tuberculosis, reactivation of latent tuberculosis, immunosuppression, malignancies, anaphylactic reactions, immunizations, macrophage activation syndrome (MAS), death"
285,IMBRUVICA,all-concat,"hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, renal failure, increased creatinine, stomatitis, dyspepsia, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, sinusitis, urinary tract infection, muscle spasms, arthropathy, pruritus, skin cancer, laceration, anxiety, insomnia, hypertension, vision blurred, contusion, oropharyngeal pain, peripheral neuropathy, second malignancies, embryo-fetal toxicity, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, progressive multifocal leukoencephalopathy (PML), death"
286,INLYTA,all-concat,"diarrhea, hypertension, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hypertensive crisis, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, elevation of liver enzymes, hepatic impairment, fetal development, death"
287,INTELENCE,all-concat,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, toxic epidermal necrolysis, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), severe rash, rash with systemic symptoms, liver transaminase elevations, severe hypersensitivity, fatal skin reactions, severe rash or rash with systemic symptoms, facial edema, eosinophilia, angioedema, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to indolent or residual opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death"
288,INVOKANA,all-concat,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increases in low-density lipoprotein cholesterol (LDL-C), urinary tract infection, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (asthenia), pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reactions, volume depletion-related adverse reactions (e.g., postural dizziness, orthostatic hypotension, syncope, dehydration), falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, phimosis, severe hypoglycemia, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, non-high-density lipoprotein cholesterol (non-HDL-C), increases in hemoglobin, decreases in bone mineral density"
289,JARDIANCE,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased low-density lipoprotein cholesterol (LDL-C), urinary tract infection, asymptomatic bacteriuria, cystitis, vulvovaginal mycotic infection, vaginal infection, vulvitis, vulvovaginal candidiasis, genital infection, genital candidiasis, genital infection fungal, genitourinary tract infection, vulvovaginitis, cervicitis, urogenital infection fungal, vaginitis bacterial, polyuria, pollakiuria, nocturia, dyslipidemia, arthralgia, male genital mycotic infections, balanoposthitis, balanitis, scrotal abscess, penile infection, nausea, thirst, polydipsia, volume depletion, blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypovolemia, orthostatic hypotension, syncope, increased urination, serum creatinine increase, eGFR decrease, overall hypoglycemic events, severe hypoglycemic events, vaginal mycotic infection, phimosis, increased hematocrit"
290,JEVTANA,all-concat,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, Neutropenia, Anemia, Leukopenia, Thrombocytopenia, Diarrhea, Fatigue, Nausea, Vomiting, Constipation, Asthenia, Abdominal Pain, Hematuria, Back Pain, Anorexia, Peripheral Neuropathy, Pyrexia, Dyspnea, Dysgeusia, Cough, Arthralgia, Alopecia, Infections, Ventricular Fibrillation, Cerebral Hemorrhage, Febrile Neutropenia, Arrhythmia, Dyspepsia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, Gastritis, Intestinal Obstruction, Gastrointestinal Hemorrhage, Gastrointestinal Perforation, Neutropenic Enterocolitis, Sepsis, Septic Shock, Increased AST, Increased ALT, Increased Bilirubin, death."
291,JUBLIA,all-concat,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, fatigue, erythema, pain, irritation, urticaria, bruising, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, wheezing, hypotension, rash, death"
293,KALYDECO,all-concat,"Transaminase Elevations, Headache, Oropharyngeal Pain, Upper Respiratory Tract Infection, Nasal Congestion, Abdominal Pain, Nasopharyngitis, Diarrhea, Rash, Nausea, Dizziness, Hypoglycemia, Rhinitis, Aspartate Aminotransferase Increased, Bacteria in Sputum, Blood Glucose Increased, Hepatic Enzyme Increased, Arthralgia, Musculoskeletal Chest Pain, Myalgia, Sinus Headache, Pharyngeal Erythema, Pleuritic Pain, Sinus Congestion, Wheezing, Acne, Non-congenital Lens Opacities/Cataracts"
294,KYPROLIS,all-concat,"cardiac toxicities, cardiac failure, myocardial infarction, myocardial ischemia, acute renal failure, tumor lysis syndrome, pulmonary toxicity, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, pulmonary hypertension, dyspnea, hypertension, hypertensive crisis, hypertensive emergency, venous thrombosis, thromboprophylaxis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, PRES, embryo-fetal toxicity, death"
295,LUMIZYME,all-concat,"anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, fluid overload, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, bradycardia, bronchospasm, throat tightness, hypotension, angioedema, chest pain, paresthesia, local swelling, diarrhea, pruritus, supraventricular tachycardia, edema, peripheral, rash papular, immune-mediated reactions, flu-like illness, arthralgia, pain, anaphylactic reactions, cardiac hypertrophy, immune complex deposition, ventricular arrhythmias, bradycardia, cardiac arrest, death"
296,MULTAQ,all-concat,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes, generalized rash, macular rash, maculo-papular rash, erythematous rash, pruritus, eczema, dermatitis, allergic dermatitis, photosensitivity reaction, dysgeusia, increases in creatinine, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis, increased risk of death, stroke, hepatocellular liver injury, acute liver failure, dyspnea, non-productive cough, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, death"
297,NATAZIA,all-concat,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, irregular uterine bleeding, headache (including migraines), breast tenderness, pain, menstrual disorders, nausea/or vomiting, acne, mood changes, increased weight, menstrual disorder (metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding), mood changes (depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying), headache (including migraines), weight increased, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, vulvovaginal candidiasis, jaundice, loss of vision, proptosis, diplopia, papilledema, retinal vascular lesions, retinal vein thrombosis, carcinoma of the breasts and reproductive organs, breast cancer, cervical cancer, intraepithelial neoplasia, hepatocellular carcinoma, hepatobiliary disorders, hepatocellular carcinoma, high blood pressure, carbohydrate and lipid metabolic effects, glucose tolerance, dyslipidemia, pancreatitis, bleeding irregularities, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, teratogenic effect, depression, laboratory test interference, hereditary angioedema, chloasma gravidarum, sun exposure, ultraviolet radiation exposure, death"
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis, hepatic effects, liver injury, severe joint pain, death"
299,NEURACEQ,all-concat,"erythema, irritation, pain, image interpretation errors, false positives, radiation risk, cancer"
300,NORTHERA,all-concat,"supine hypertension, hyperpyrexia, confusion, exacerbate existing ischemic heart disease, arrhythmias, congestive heart failure, headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope, allergic reactions, death"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, post-transplant lymphoproliferative disorder, other malignancies, progressive multifocal leukoencephalopathy (PML), bacterial infections, mycobacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, herpes infections, infusion reactions, anaphylaxis, drug hypersensitivity, hypotension, hypertension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, hypercholesterolemia, hyperglycemia, hypocalcemia, hypophosphatemia, hypomagnesemia, hyperuricemia, graft loss, blood pressure increase, antihypertensive medication use, cholesterol increase, HDL decrease, LDL increase, triglycerides increase, infections and infestations, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, abdominal pain upper, hypokalemia, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, proteinuria, dysuria, renal tubular necrosis, hematoma, lymphocele, cough, dyspnea, blood creatinine increased, arthralgia, back pain, headache, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, death."
302,ONFI,all-concat,"somnolence, sedation, potentiation of sedation, withdrawal symptoms, serious dermatological reactions, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, constipation, pyrexia, lethargy, drooling, ataxia, aggression, fatigue, insomnia, vomiting, dysphagia, irritability, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, psychomotor hyperactivity, dysarthria, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial edema, lip edema, Stevens-Johnson syndrome, toxic epidermal necrolysis, convulsions, psychosis, tremor, dysphoria, status epilepticus"
303,OTEZLA,all-concat,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, depression, suicidal thoughts, suicidal behavior, back pain, fatigue, insomnia, frequent bowel movements, bronchitis, tooth abscess, folliculitis, sinus headache, death"
304,PICATO,all-concat,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis, severe eye pain, anaphylaxis"
305,POTIGA,all-concat,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, suicidal ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
306,PRADAXA,all-concat,"bleeding, hemorrhage, gastrointestinal hemorrhage, diarrhea, dyspepsia, nausea, upper abdominal pain, intracranial hemorrhage, intracerebral hemorrhage, subarachnoid hemorrhage, subdural hemorrhage, hemorrhagic stroke, gastrointestinal events, gastrointestinal adverse reactions, gastritis-like symptoms, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, thrombocytopenia, esophageal ulcer, thrombotic events, spinal/epidural hematoma, myocardial infarction, fatal bleeding, death"
307,PRISTIQ,all-concat,"Hypersensitivity, Suicidal Thoughts and Behaviors, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, male sexual function disorders, blood pressure increased, dry mouth, vomiting, fatigue, chills, feeling jittery, decreased appetite, tremor, disturbance in attention, insomnia, nervousness, abnormal dreams, urinary hesitation, yawning, hyperhidrosis, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion, proteinuria, orthostatic hypotension, Stevens-Johnson syndrome, death"
308,PROLIA,all-concat,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, pancreatitis, death, new malignancies, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, cataracts, hypersensitivity reactions, anaphylaxis, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe bone, joint, muscle pain, marked elevation in serum PTH, drug-related hypersensitivity reactions, opportunistic infections, endocarditis, erysipelas, cellulitis, eczema, suppression of bone turnover, severe renal impairment, immunogenicity."
309,PROMACTA,all-concat,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, vitamin D deficiency, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, Thrombotic microangiopathy with acute renal failure, ascites, encephalopathy, portal vein thromboses, pain in extremity."
310,QUTENZA,all-concat,"application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor, eye and mucous membrane exposure, aerosolization of capsaicin, unintended skin exposure, application associated pain, increase in blood pressure"
311,SAPHRIS,all-concat,"dementia-related psychosis, death, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hyperglycemia, Dyslipidemia, Weight Gain, Hypersensitivity Reactions, Anaphylaxis, Angioedema, Application site reactions, oral ulcers, blisters, peeling/sloughing, inflammation, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Cerebrovascular Adverse Events, stroke, transient ischemic attack, choking, oropharyngeal muscular dysfunction, hypoesthesia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, depression, pain in extremity, arthralgia, dyspepsia, toothache, headache, suicidal ideation, anger, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, tachycardia, heart rate increased, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, diplopia, vision blurred, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, parkinsonism, dyskinesia, dystonia, oculogyration, muscle rigidity, gait disturbance, masked facies, tremor, bradykinesia, muscle contractions involuntary, muscle twitching, musculoskeletal stiffness, protrusion tongue, resting tremor, galactorrhea, amenorrhea, gynecomastia, impotence, edema peripheral, bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, thrombocytopenia, anemia"
312,SIMPONI,all-concat,"serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, lupus-like syndrome, ANA-positive, anti-dsDNA antibodies, infusion reaction, immunogenicity, antibodies to SIMPONI ARIA, neutralizing antibodies, pyrexia, leukopenia, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, dizziness, paresthesia, constipation, melanoma, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, interstitial lung disease, skin exfoliation, bullous skin reactions, congestive heart failure, demyelinating disorders, multiple sclerosis, Guillain-Barre syndrome, optic neuritis, peripheral demyelinating polyneuropathy, pancytopenia, aplastic anemia, thrombocytopenia, lymphoma, non-Hodgkin's lymphoma, leukemia, hepatosplenic T-cell lymphoma, Merkel cell carcinoma, death"
313,SIRTURO,all-concat,"increased mortality, death, QT prolongation, hepatotoxicity, drug interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, aminotransferase elevations, ventricular arrhythmia, liver injury, fatigue, jaundice, dark urine, liver tenderness, hepatomegaly, bilirubin elevation, syncope"
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, upper respiratory infection, dizziness, arthralgia, diarrhea, gastroenteritis viral, Non-arteritic anterior ischemic optic neuropathy (NAION), priapism, cavernosal fibrosis, Peyronie's disease, sudden loss of hearing, tinnitus, symptomatic hypotension, lightheadedness, fainting, bleeding disorders, peptic ulceration, sexually transmitted diseases, Human Immunodeficiency Virus (HIV)"
315,STRIBILD,all-concat,"lactic acidosis, severe hepatomegaly with steatosis, death, severe acute exacerbations of hepatitis B, new onset or worsening renal impairment, bone effects of tenofovir DF, immune reconstitution syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, skin discoloration, hyperpigmentation, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, increased creatinine, proteinuria, polyuria, asthenia, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to indolent or residual opportunistic infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
316,TAFINLAR,all-concat,"new primary malignancies, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, embryofetal toxicity, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, pancreatitis, hypersensitivity, bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT prolongation, retinal vein occlusion, interstitial lung disease, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, non-cutaneous malignancies, RAS mutation-positive non-cutaneous malignancies, deep vein thrombosis, pulmonary embolism, LVEF decrease, retinal pigment epithelial detachment, uveitis, iritis, fever, dehydration, renal failure, syncope, serious skin toxicity, secondary infections of the skin, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, hyperglycemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, death"
317,TANZEUM,all-concat,"thyroid C-cell tumors, acute pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, gamma glutamyltransferase (GGT) increase, heart rate increase"
318,TECFIDERA,all-concat,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy (PML), lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia, death"
319,TEFLARO,all-concat,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, hypersensitivity, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis, death"
320,TIVICAY,all-concat,"hypersensitivity reactions, effects on serum liver biochemistries, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, liver injury, worsening or development of transaminase elevations, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to infections, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
321,TOVIAZ,all-concat,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation, death"
322,TREANDA,all-concat,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, cough, constipation, headache, mucosal inflammation, stomatitis, worsening hypertension, hypertensive crisis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, hypersensitivity, chills, nasopharyngitis, herpes simplex, weight decreased, hyperuricemia, rash, pruritus, hemoglobin decreased, platelets decreased, leukocytes decreased, bilirubin elevations, increased AST, increased ALT, creatinine levels changes, tachycardia, diarrhea, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, anorexia, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, dizziness, dysgeusia, insomnia, anxiety, depression, dyspnea, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, hypotension, neutropenic sepsis, diffuse alveolar hemorrhage, opportunistic infection (CMV), septic shock, anaphylactic reactions, anaphylactoid reactions, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, injection or infusion site reactions, phlebitis, irritation, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, embryo-fetal toxicity, fetal harm, resorptions, skeletal and visceral malformations, decreased fetal body weights, death"
323,TRULICITY,all-concat,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, Nausea, Diarrhea, Vomiting, Abdominal Pain, Decreased Appetite, Dyspepsia, Fatigue, Constipation, Flatulence, Abdominal distension, Gastroesophageal reflux disease, Eructation, Heart Rate Increase, Tachycardia, Sinus tachycardia, Immunogenicity, Anti-drug antibodies, Hypersensitivity, Systemic hypersensitivity, Injection-site reactions, PR Interval Prolongation, First Degree Atrioventricular (AV) Block, Amylase Increase, Lipase Increase, Medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)"
324,TUDORZA,all-concat,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, death"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, neonatal gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, allergic dermatitis, irritant dermatitis."
326,ULORIC,all-concat,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, gout flare, cardiovascular thromboembolic events, myocardial infarction, stroke, hepatic failure (death), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions."
327,VICTRELIS,all-concat,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, agranulocytosis, thrombocytopenia, diarrhea, vomiting, dry mouth, embryofetal toxicity, death"
328,VIMIZIM,all-concat,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, retching, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression (SCC), paralysis, urinary incontinence, fecal incontinence, death"
329,VIZAMYL,all-concat,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, hypersensitivity reactions, radiation risk, image interpretation errors, death"
330,VORAXAZE,all-concat,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
331,XALKORI,all-concat,"hepatotoxicity, Interstitial Lung Disease, ILD, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, death, abdominal pain, pyrexia, weight increased, pain in extremity, muscle spasm, dizziness, headache, fatigue, neuropathy, gait disturbance, hypoaesthesia, muscular weakness, neuralgia, neuropathy peripheral, paraesthesia, peripheral sensory neuropathy, polyneuropathy, sensory disturbance, rash, renal cyst, syncope, neutropenia, lymphopenia, ALT elevation, AST elevation, hypophosphatemia, hypokalemia, pneumonia, arrhythmia, acute respiratory distress syndrome, respiratory failure, sepsis, hepatic failure, embryofetal toxicity"
332,XEOMIN,all-concat,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscular weakness, muscle spasm, dysarthria, myalgia, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphonia, urinary incontinence, corneal exposure, ulceration, ectropion, death"
333,XIAFLEX,all-concat,"tendon ruptures, serious injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin laceration (tear), blood blister, injection site hematoma, injection site swelling, ecchymosis, penile ""popping"" sounds or sensations, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, hypersensitivity reactions, anaphylaxis, allergic reactions, IgE-anti-drug antibodies, ecchymosis/contusion, injection site hemorrhage, penile ecchymosis, risk of bleeding in patients with abnormal coagulation, death"
334,XTANDI,all-concat,"seizure, asthenia, fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness, vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract infection, lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, sepsis, fall-related injuries, joint injuries, hematomas, hypertensive crisis, death"
335,YERVOY,all-concat,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, gastrointestinal disorders, skin and subcutaneous tissue disorders, general disorders and administration site conditions, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), hypersensitivity, anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis, Guillain-Barre syndrome, myasthenia gravis, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, hypophysitis, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, death"
336,ZERBAXA,all-concat,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, tachycardia, angina pectoris, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, infusion site reactions, candidiasis, oropharyngeal, fungal urinary tract infection, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, hyperglycemia, hypomagnesemia, hypophosphatemia, ischemic stroke, dyspnea, urticaria, venous thrombosis, death"
337,ZYDELIG,all-concat,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, febrile neutropenia, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, lymphocyte count decreased, lymphocyte count increased, hemoglobin decreased, platelets decreased, death"
338,ZYKADIA,all-concat,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity, Diarrhea, Nausea, Elevated Transaminases, Vomiting, Abdominal Pain, Fatigue, Decreased Appetite, Constipation, Convulsion, Pneumonia, Dyspnea, Dehydration, Respiratory Failure, Pneumothorax, Gastric Hemorrhage, General Physical Health Deterioration, Pulmonary Tuberculosis, Cardiac Tamponade, Sepsis, Hemoglobin Decreased, Alanine Transaminase Increased, Aspartate Transaminase Increased, Creatinine Increased, Glucose Increased, Phosphate Decreased, Lipase Increased, Bilirubin Increased, Neuropathy, Vision Disorder, Prolonged QT Interval, Esophageal Disorder, Rash, death"
339,ZYTIGA,all-concat,"hypertension, hypokalemia, fluid retention, Mineralocorticoid Excess, Adrenocortical Insufficiency, Hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, chest discomfort, cardiac failure, non-infectious pneumonitis, myopathy, rhabdomyolysis, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, myocardial ischemia, myocardial infarction, death"
